Schedule 13G ownership disclosure
Maravai LifeSciences Holdings Inc
Class A Common Stock, par value $0.01 per share · CUSIP: 56600D107
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 12 West Capital Management LP
Shares: 11,591,335.00 · Class: 8.2%
- Joel Ramin
Shares: 11,591,335.00 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-000500
- Form type
- SCHEDULE 13G/A
- Filer
- 12 West Capital Management LP
- CIK
- CIK 1540531
- Filed
- Jan 28, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership